Changes in metabolic-related variables during chronic morphine treatment

Area of Science:

• Neuroendocrinology
• Neuropharmacology
• Metabolic research

Background:

• Chronic morphine use leads to significant metabolic disturbances.
• Understanding the underlying neuroendocrine and neurochemical mechanisms is crucial.

Purpose of the Study:

• To investigate the hormonal, transcriptional, and behavioral changes associated with chronic morphine administration.
• To identify the neurochemical basis for morphine-induced metabolic alterations.

Main Methods:

• Adult male Wistar rats received slow-release morphine implants for 8 days.
• Hormonal (leptin, insulin, adiponectin, ACTH) and gene expression levels were analyzed.
• FosB/Delta FosB, POMC, CART, orexin, and NPY expression in brain regions were assessed.
• Feeding behavior and body weight changes were monitored.

Main Results:

• Morphine-treated rats showed reduced body weight gain, decreased food intake, and lower caloric efficiency.
• Diurnal feeding frequency increased, while nocturnal feeding decreased.
• Plasma leptin and insulin levels were significantly lower; adiponectin and ACTH remained unchanged.
• Increased FosB/Delta FosB immunoreactivity was observed in key appetite-regulating brain areas.
• No significant changes in POMC or CART expression were found, but NPY expression was upregulated.

Conclusions:

• Chronic morphine induces significant metabolic alterations primarily through changes in feeding behavior and caloric efficiency.
• Neurochemical adaptations in specific brain nuclei, including FosB/Delta FosB induction and altered NPY expression, contribute to these metabolic changes.
• Key anorexigenic peptides are not directly affected, suggesting complex regulatory pathways involved in morphine-induced metabolic dysregulation.